Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05520476 · ClinicalTrials.gov registry record
Neuroliten MVP System Clinical Observation Study
A clinical trial of Epilepsy, sponsored by Enliten AI.
- Active
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05520476: Active study of Epilepsy, sponsored by Enliten AI.
NCT05520476 is a study of Epilepsy that is active but no longer recruiting, run by Enliten AI. The registered enrollment target is 20 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05520476, a study of Epilepsy, is active but no longer recruiting, sponsored by Enliten AI.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study for data collection from subjects diagnosed with Epilepsy/intractable seizures. The Neuroliten MVP System will not be used for patient management or treatment decisions.
Conditions Studied
Interventions
- DEVICE Neuroliten MVP system
Study Locations (1)
Colorado
- University of Colorado - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2024-12 |
What the registry record for NCT05520476 still lists
NCT05520476 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Neuroliten MVP system is the first listed.
NCT05520476 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05520476 about?
NCT05520476 is a clinical study titled "Neuroliten MVP System Clinical Observation Study". This is an observational study for data collection from subjects diagnosed with Epilepsy/intractable seizures. The Neuroliten MVP System will not be used for patient management or treatment decisions.
What is the current status of trial NCT05520476?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2022-10-31. Estimated completion is 2024-12.
What conditions does trial NCT05520476 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT05520476?
The interventions under investigation include: Neuroliten MVP system (DEVICE).
Who is sponsoring clinical trial NCT05520476?
This trial is sponsored by Enliten AI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05520476 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05520476's enrollment target sits among peer trials
20 131st of 160 higher than 24 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI